Skip to Main Content

Paper Details

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification.
NPJ Precis Oncol
11
2021
AKT, CTNNB1, CTNNB1-mutant, ER, EnOC, Endometrioid ovarian carcinoma, MAPK, PARP, PI3K, PR, PR-low tumours, Patients, TP53, endometrioid ovarian carcinoma, oestrogen, oestrogen receptor, ovarian cancer, p53, patient, patients, progesterone, progesterone and, tumours, wild
Author NameAffiliation
John P ThomsonMRC Institute of Genetics and Cancer, University of Edinburgh
Alison MeynertMRC Institute of Genetics and Cancer, University of Edinburgh
Colin A SempleMRC Institute of Genetics and Cancer, University of Edinburgh
Colin A SempleMRC Institute of Genetics and Cancer, University of Edinburgh
  • 1 - 4

Datasets

Release 1.2